How to Buy Boston Scientific Stock
Boston Scientific Corp
Boston Scientific is a medical device company located in Massachusetts, United States, which is part of the Healthcare sector, and is traded under the ticker BSX on the NYSE exchange.
Boston Scientific stock last closed at $99.74, up 1.2% from the previous day, and has increased 29.6% in one year. It has overperformed other stocks in the Medical Devices industry by 0.46 percentage points. Boston Scientific stock is currently +38.76% from its 52-week low of $71.88, and -6.93% from its 52-week high of $107.17.
At the moment, there are 1.48B BSX shares outstanding. The market capitalization of BSX is $147.56B. In the past 24 hours, 10.33M BSX shares were traded.
How to Buy Boston Scientific Stock
Not sure how to invest in Boston Scientific stock? Here's how.
- Choose where to buy Boston Scientific stock: You need to choose an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you figure out where to buy Boston Scientific stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Choose your payment method and add your details.
- Evaluate Boston Scientific stock: The Boston Scientific ticker symbol is BSX. Is Boston Scientific stock a good investment? Should you buy shares of BSX? How do BSX's underlying business fundamentals look? Do top analysts think Boston Scientific is a good buy? Why has BSX's stock price moved recently? (Hint: Our stock research website can help you figure out if BSX is a good stock to buy).
- Execute your BSX trade: Decide if you will purchase BSX shares at the current market price or use a limit order to purchase BSX shares at a given price.
- Monitor your BSX investment: Create a watchlist to important notifications about your new investment in Boston Scientific shares.
Step 1: Choose where to buy Boston Scientific stock
You will need an online brokerage account to access the NYSE market and buy BSX shares.
Our preferred brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the right brokerage, it's time to fill out some personal info so you are able to buy BSX stock today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to create your new trading account.
- Submit your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've opened your account on a mobile trading app, you can securely and quickly fund your account:
Watch the walkthrough below if you need help depositing funds into your brokerage account.
Step 4: Evaluate Boston Scientific stock
Once you have figured out the best place to buy Boston Scientific stock, it's crucial to research their stock before you buy, so you truly understand the risk and opportunity.
Boston Scientific quick stats
Boston Scientific Due Diligence Checks
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis.
You can see all of the due diligence checks on BSX's stock page.
Is BSX stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge BSX's true value.
Using relative valuations ratios:
- BSX may be overvalued based on its P/E ratio of 72.28x, relative to Medical Devices industry P/E ratio of 35.6x
- BSX could be overvalued based on its P/B ratio of 6.64x, relative to Medical Devices industry P/B ratio of 3.99x
- BSX could be overvalued based on its PEG ratio of 1.88x
You can do additional valuation analysis on BSX's stock here.
BSX Financial Health Summary
Positive Health Checks:
- BSX earnings of $2.80B is not sufficient to cover its interest payments.
- BSX's operating cash flow of $3.81B allows it to safely service it's debt of $11.31B.
- Total BSX debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the BSX balance sheet.
Negative Health Checks:
- There are more long-term liabilities than short-term assets on the BSX balance sheet.
- BSX has a relatively high debt to equity ratio of 0.8.
- BSX profit margin has gone down from 12% to 11.6% in the past year.
Is BSX stock a Buy, Hold, or Sell, according to analysts?
Out of 14 Wall Street analysts who monitor BSX, the consensus analyst rating on Boston Scientific is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Latest BSX Analyst Ratings
Shagun Singh, a bottom 14% analyst from RBC Capital maintains BSX with a buy rating and raises their BSX price target from $116.00 to $120.00, on Apr 24, 2025.
Richard Newitter, a top 6% analyst from Truist Securities maintains BSX with a strong buy rating and raises their BSX price target from $113.00 to $117.00, on Apr 24, 2025.
Truist Securities's Richard Newitter raised their price target on Boston Scientific (NYSE: BSX) by 3.5% from $113 to $117 on 2025/04/24. The analyst maintained their Strong Buy rating on the stock.
Boston Scientific reported its Q1 2025 earnings.
Newitter said the "impressive" quarter delivered revenue and margin outperformance, and noted that management's guidance is absorbing the 2H 2025 tariff impact.
Earnings Report
For Q1 2025, Boston Scientific reported:
- EPS of $0.75, which beat Zacks Consensus Estimate by 11.9% and Q1 2024 by 33.9%.
- Revenue of $4.66B, which beat the Zacks Consensus Estimate by 2.3% and Q1 2024 by 20.9%.
Management guided:
For Q2 2025:
- EPS of $0.71 to $0.73.
- 17.5% to 19.5% revenue growth.
For FY 2025:
- EPS of $2.87-$2.94, up from the prior $2.80 to $2.87.
- 15% to 17% revenue growth, up from the prior 12.5% to 14.5%.
Chairman & CEO Mike Mahoney commented: "We delivered an exceptional quarter to start the year, reflecting the effectiveness of our highly engaged global team and the strength of our product portfolio.
"We remain well-positioned for the future as we continue to focus on meaningful innovation, clinical science and the execution of our category leadership strategy to drive differentiated growth and performance for the long-term."
Vijay Kumar, a bottom 4% analyst from Evercore ISI Group maintains BSX with a buy rating and raises their BSX price target from $110.00 to $112.00, on Apr 24, 2025.
David Rescott, a top 19% analyst from Baird maintains BSX with a buy rating and raises their BSX price target from $115.00 to $120.00, on Apr 24, 2025.
Rick Wise, a top 9% analyst from Stifel Nicolaus maintains BSX with a strong buy rating and raises their BSX price target from $115.00 to $120.00, on Feb 10, 2025.
You can dig deeper into what analysts are forecasting on the Boston Scientific stock forecast page.
BSX Technicals
BSX Earnings
Last year, BSX earnings were $2.03B. In the past five year, BSX's earnings have grown by -14.83% per year. This was slower than the Medical Devices industry average of 12.15%.
Last year, BSX revenue was $17.55B. During the past 5 year, BSX's revenue has increased by 10.23% per year. This was faster than the Medical Devices industry average of 9.62%.
Find out more about BSX's earnings and revenue performance here.
What are BSX insiders up to?
In the last 12 months, insiders at BSX have sold more shares than they have bought.
Joseph Michael 1. Fitzgerald, EVP Group Pres Cardiology of BSX, was the latest BSX insider to buy. They bought $1,474,127.80 worth of BSX stock on Jun 4, 2025.
Dig into more about who owns BSX stock here.
Does BSX stock generate passive income?
No, Boston Scientific doesn't provide an income stream by paying out dividends.
What do other traders have to say about BSX?
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your BSX trade
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are generally sufficient. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a specific dollar amount, place a limit order.
Press the Open Trade button and eToro will execute your order.
If you want additional info about buying stocks on eToro, click the how to video below:
Step 6: Monitor your BSX investment
Now that you own some BSX stock, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to get notified of the latest news about your BSX stock.
BSX Feed
How to Buy Stock in Boston Scientific
To summarize, here are the 6 steps you need to take to buy Boston Scientific stock right now:
- Choose where to buy Boston Scientific stock
- Sign up for a brokerage account
- Deposit money your brokerage account
- Evaluate Boston Scientific stock
- Execute your BSX trade
- Monitor your BSX investment
If you require a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Boston Scientific, click the button below.
Other Articles You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.